Last Updated: 03/10/2025

Understanding the mechanism by which Plasmodium falciparum rapidly acquires drug resistance and applying it to treatment, focusing on the host environment

Objectives

The objectives of this study are to:

  1. elucidate the relationship between the resulting changes in the host microenvironment and drug sensitivity through both culture and animal models and clinical research by focusing on the phenomenon of adhesion to vascular endothelium, which is unique to this species;
  2. track the emergence of drug resistance using an accelerated evolution model; and
  3. realize a “treatment that does not develop resistance” that goes beyond the race between resistance emergence and new drug development by elucidating the comprehensive mechanism that accelerates resistance evolution.
Principal Institution

Juntendo University, Japan

Principal Investigators / Focal Persons

Naoto Fukuda

Partner Investigators

Makoto Hirai
Toshihiro Mita

Rationale and Abstract

Plasmodium falciparum has acquired resistance to multiple drugs, including the effective drug artemisinin, but the reason why this species rapidly develops resistance is unknown. 

Date

Apr 2025 — Mar 2029

Total Project Funding

$124,457

Funding Details
Project Site

Japan

SHARE
SHARE